Intervention Review

Aldose reductase inhibitors for the treatment of diabetic polyneuropathy

  1. Colin Chalk1,*,
  2. Tim J Benstead2,
  3. Fraser Moore3

Editorial Group: Cochrane Neuromuscular Disease Group

Published Online: 17 OCT 2007

Assessed as up-to-date: 21 AUG 2007

DOI: 10.1002/14651858.CD004572.pub2


How to Cite

Chalk C, Benstead TJ, Moore F. Aldose reductase inhibitors for the treatment of diabetic polyneuropathy. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD004572. DOI: 10.1002/14651858.CD004572.pub2.

Author Information

  1. 1

    McGill University, Medicine and Neurology & Neurosurgery, Montreal, Quebec, Canada

  2. 2

    Dalhousie University/Capital Health, Medicine, Halifax, Nova Scotia, Canada

  3. 3

    McGill University, Department of Neurology and Neurosurgery, Montreal, Quebec, Canada

*Colin Chalk, Medicine and Neurology & Neurosurgery, McGill University, Montreal General Hospital - Room L7-313, 1650 Cedar Avenue, Montreal, Quebec, H3G 1A4, Canada. colin.chalk@mcgill.ca.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 17 OCT 2007

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.